NCT06316336View on ClinicalTrials.gov

Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed Conditions

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

June 22, 2024

Study Completion Date

June 28, 2024

Conditions
Healthy Vollunteer
Interventions
DRUG

Alfuzosin Hydrochloride 10 mg

Alfuzosin Hydrochloride 10 mg (test durg)

DRUG

Xatral® XL 10 mg

Xatral® XL 10 mg (reference drug)

Sponsors

Lead Sponsor

Pharma Nueva
All Listed Sponsors
lead

Pharma Nueva

INDUSTRY

NCT06316336 - Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter